Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MFG | IBN |
|---|---|---|
| Price | $10.51 | $27.84 |
| Change today | ▼ 2.19% | ▼ 0.25% |
| Market cap | $127.82B | $99.92B |
| Return, 3 months | +9.7% | -3.2% |
| Return, year to date | +45.2% | -5.8% |
| Return, 1 year | +58.8% | -9.3% |
| P/E (TTM) | 16.5 | 17.8 |
| P/B | 1.8 | 2.6 |
| P/E percentile vs own 5y | 92nd | 17th |
| Dividend yield | 1.66% | 0.83% |
| Revenue growth (YoY, latest qtr) | +35.7% | +7.7% |
| Net profit growth (YoY) | +45.5% | +12.6% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 30.4% | 24.8% |
| Return on equity | 12.5% | 15.8% |
| Analyst target vs. price | – | – |
| Analyst buy share | 100% | 100% |
| RSI (14) | 48 | 34 |
| 30-day volatility | 29.8% | 19.3% |
| Max drawdown, 1 year | -24.8% | -23.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.